C19H38N6O10
Neat
510.55
6''-O-Carbamoyltobramycin; Nebramycin V'; Nebramycin factor 5'; 51736-77-7; nebramycin 5'; tobramycin carbamate; 837245T11O; CHEBI:73686; (1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-[(2, 6-diamino-2, 3, 6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-6-O-carbamoyl-3-deoxy-alpha-D-glucopyranoside; (1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-((2, 6-diamino-2, 3, 6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy)-2-hydroxycyclohexyl 3-amino-6-O-carbamoyl-3-deoxy-alpha-D-glucopyranoside; RefChem:103620; [(2R, 3S, 4S, 5R, 6S)-4-amino-6-[(1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-[(2R, 3R, 5S, 6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3, 5-dihydroxyoxan-2-yl]methyl carbamate; Nebramycin-5'; 6-O-Carbamoyltob; Tobramycin Impurity 10; Tobramycin Impurity N1; SCHEMBL30687245; DTXSID10966042; UNII-837245T11O; D-Streptamine, O-3-amino-6-O-(aminocarbonyl)-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2, 6-diamino-2, 3 and 6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-4))-2-deoxy-
[(2R, 3S, 4S, 5R, 6S)-4-amino-6-[(1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-[(2R, 3R, 5S, 6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3 and 5-dihydroxyoxan-2-yl]methyl carbamate
InChI=1S/C19H38N6O10/c20-3-9-8(26)2-7(23)17(32-9)34-15-5(21)1-6(22)16(14(15)29)35-18-13(28)11(24)12(27)10(33-18)4-31-19(25)30/h5-18,26-29H,1-4,20-24H2,(H2,25,30)/t5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1